Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-08-02
1984-02-14
Raymond, Richard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242484, 544101, A61K 31535
Patent
active
044316470
ABSTRACT:
The (R,R)-enantiomers of trans-indeno[1,2-b]-1,4-oxazines demonstrate dopaminergic activity, whereas the (S,S)-enantiomers demonstrate .alpha.-adrenergic antagonist activity. They are prepared by cyclization of the appropriate chiral 2-amino-1-hydroxyindane.
REFERENCES:
patent: 3642789 (1972-02-01), Faith et al.
McClure et al., J. Org. Chem., 46, 2431 (l981).
Craig et al., J. Org. Chem., 39, 1669 (1974).
Merck & Co. , Inc.
Monaco Mario A.
Nicholson William H.
Raymond Richard
LandOfFree
Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2374909